• 1
    Draetta GF. Mammalian G1 cyclins. Curr Opin Cell Biol 1994; 6: 8426.
  • 2
    Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 57382.
  • 3
    Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 5515.
  • 4
    Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 32330.
  • 5
    Motokura T, Arnold A. Cyclin D and oncogenesis. Curr Opin Genet Dev 1993; 3: 510.
  • 6
    Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 105965.
  • 7
    Won KA, Xiong Y, Beach D, Gilman MZ. Growth-regulated expression of d-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci USA 1992; 89: 991014.
  • 8
    Jiang W, Kahn SM, Zhou P et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993; 8: 344757.
  • 9
    Zhou P, Jiang W, Zhang YJ et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 1995; 11: 57180.
  • 10
    Arber N, Doki Y, Han EK et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res 1997; 57: 156974.
  • 11
    Quelle DE, Ashmun RA, Shurtleff SA et al. Overexpression of mouse d-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7: 155971.
  • 12
    Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994; 14: 166979.
  • 13
    Imoto M, Doki Y, Jiang W, Han EK, Weinstein IB. Effects of cyclin D1 overexpression on G1 progression-related events. Exp Cell Res 1997; 236: 17380.
  • 14
    Shintani M, Okazaki A, Masuda T et al. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression. Anticancer Res 2002; 22: 63947.
  • 15
    Harada H, Nakagawa K, Iwata S et al. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. Cancer Res 1999; 59: 37839.
  • 16
    Kornmann M, Arber N, Korc M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest 1998; 101: 34452.
  • 17
    Warenius HM, Seabra LA, Maw P. Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not c-raf-1 protein. Int J Cancer 1996; 67: 22431.
  • 18
    Simizu S, Shibasaki F, Osada H. Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells. Jpn J Cancer Res 2000; 91: 70614.
  • 19
    Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res 1998; 58: 205762.
  • 20
    Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 1994; 9: 3236.
  • 21
    Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001; 411: 101721.
  • 22
    Tashiro E, Maruki H, Minato Y, Doki Y, Weinstein IB, Imoto M. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway. Cancer Res 2003; 63: 42431.
  • 23
    Hsiao KM, McMahon SL, Farnham PJ. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev 1994; 8: 152637.
  • 24
    Johnson DG, Ohtani K, Nevins JR. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 1994; 8: 151425.
  • 25
    Neuman E, Flemington EK, Sellers WR, Kaelin WG Jr. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 1994; 14: 660715.
  • 26
    Tashiro E, Minato Y, Maruki H, Asagiri M, Imoto M. Regulation of FGF receptor-2 expression by transcription factor E2F-1. Oncogene 2003; 22: 56305.
  • 27
    Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183232.
  • 28
    Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991; 49: 3238.
  • 29
    Di Renzo MF, Olivero M, Serini G et al. Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium. J Endocrinol Invest 1995; 18: 1349.
  • 30
    Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7: 16597.
  • 31
    Liotta LA, Kohn EC. The microenvironment of the tumour–host interface. Nature 2001; 411: 3759.
  • 32
    Dow JK. deVere White RW. Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology 2000; 55: 8006.
  • 33
    Hamamoto T, Gunji S, Tsuji H, Beppu T. Leptomycins A and B, new antifungal antibiotics. I. Taxonomy of the producing strain and their fermentation, purification and characterization. J Antibiot (Tokyo) 1983; 36: 63945.
  • 34
    Fornerod M, Ohno M, Yoshida M, Mattaj IW. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997; 90: 105160.
  • 35
    Kudo N, Wolff B, Sekimoto T et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res 1998; 242: 5407.
  • 36
    Kudo N, Matsumori N, Taoka H et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci USA 1999; 96: 911217.
  • 37
    Nishi K, Yoshida M, Fujiwara D, Nishikawa M, Horinouchi S, Beppu T. Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J Biol Chem 1994; 269: 63204.
  • 38
    Yoshida M, Beppu T. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res 1988; 177: 12231.
  • 39
    Yoshida M, Nishikawa M, Nishi K, Abe K, Horinouchi S, Beppu T. Effects of leptomycin B on the cell cycle of fibroblasts and fission yeast cells. Exp Cell Res 1990; 187: 1506.
  • 40
    Tsuchiya A, Tashiro E, Yoshida M, Imoto M. Involvement of protein phosphatase 2A nuclear accumulation and subsequent inactivation of activator protein-1 in leptomycin B-inhibited cyclin D1 expression. Oncogene 2006; Sep 11, [Epub ahead of print].
  • 41
    Bannister AJ, Oehler T, Wilhelm D, Angel P, Kouzarides T. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 1995; 11: 250914.
  • 42
    Ramirez CJ, Haberbusch JM, Soprano DR, Soprano KJ. Retinoic acid induced repression of AP-1 activity is mediated by protein phosphatase 2A in ovarian carcinoma cells. J Cell Biochem 2005; 96: 17082.
  • 43
    Al-Murrani SW, Woodgett JR, Damuni Z. Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity. Biochem J 1999; 341: 2938.
  • 44
    Alberts AS, Deng T, Lin A et al. Protein phosphatase 2A potentiates activity of promoters containing AP-1-binding elements. Mol Cell Biol 1993; 13: 210412.
  • 45
    Watanabe G, Howe A, Lee RJ et al. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci USA 1996; 93: 12 861–6.
  • 46
    Whang YM, Kim YH, Kim JS, Yoo YD. RASSF1A suppresses the c-Jun – NH2-kinase pathway and inhibits cell cycle progression. Cancer Res 2005; 65: 368290.
  • 47
    Shiozawa T, Miyamoto T, Kashima H, Nakayama K, Nikaido T, Konishi I. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence. Oncogene 2004; 23: 860310.
  • 48
    Wisdom R, Johnson RS, Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. Embo J 1999; 18: 18897.
  • 49
    Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. Embo J 2000; 19: 205668.